Boc-Cys(Me)-OH

Boc-Cys(Me)-OH is a Boc-protected cysteine derivative bearing a methylated thioether side chain, providing a protected thiol-equivalent functionality that is stable under peptide-coupling conditions while maintaining the cysteine backbone geometry for downstream assembly. The tert-butoxycarbonyl (Boc) group protects the amino functionality for controlled peptide intermediate synthesis, and the S-methyl substitution is commonly used to manage cysteine reactivity during segment coupling and purification workflows.

1. Peptide Segment Coupling

Boc-Cys(Me)-OH is used as a cysteine-containing building block in peptide synthesis workflows where thiol reactivity needs to be moderated during coupling and handling. Peptide chemistry teams select this derivative to incorporate a cysteine residue into peptide segments with reduced risk of disulfide scrambling or side reactions that can occur with free thiols, particularly during iterative assembly and purification. The Boc-protected amino group supports standard peptide intermediate strategies, enabling reliable incorporation into protected peptide fragments intended for subsequent deprotection and conversion steps within a larger synthesis plan.

2. Disulfide-Controlled Synthesis

Boc-Cys(Me)-OH is frequently employed in synthetic routes that require controlled cysteine chemistry for later formation or manipulation of disulfide bonds. In custom peptide manufacturing and research-grade peptide development, the S-methyl thioether provides a practical way to carry the cysteine side chain through early stages without introducing the high nucleophilicity and oxidation sensitivity associated with unprotected cysteine thiols. This makes the derivative useful for preparing cysteine-containing intermediates that will later be transformed under conditions chosen by the project team to generate the desired thiol/disulfide state in the final peptide.

3. Pharmaceutical Intermediate Development

Boc-Cys(Me)-OH is also used as a protected amino acid intermediate for medicinal chemistry programs that require cysteine-bearing peptidomimetics, linker-containing fragments, or peptide-like scaffolds. In small-molecule and peptide conjugate development, the derivative offers a manageable cysteine handle during synthesis and purification of advanced intermediates, helping maintain functional-group integrity across multi-step sequences. Teams developing complex coupling partners and late-stage functionalized fragments often rely on such protected cysteine building blocks to reduce side reactions and improve reproducibility of intermediate quality.

4. Cysteine-Containing Library Synthesis

Boc-Cys(Me)-OH supports peptide library construction where cysteine residues must be introduced consistently across multiple analogs. Research groups performing parallel synthesis and structure-activity relationship studies use this derivative to standardize the cysteine incorporation step while minimizing variability caused by thiol oxidation or disulfide formation during the build. The Boc protection and thioether side-chain substitution help maintain a stable intermediate profile through coupling cycles, enabling more uniform downstream processing when the library members are carried forward to deprotection or final functionalization steps.

1. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. Myotropic activity of allatostatins in tenebrionid beetles

5. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging